Skip navigation
>»
RSS feed for this page
Know something we don't? Submit a conference announcement
Choose Category:

Oncology meetings & conferences

27 meetings & conferences listed in Oncology 

Society for Neuro-Oncology Scientific Meeting and Education Day
United States
Florida
11/13/2014

Society for Neuro-Oncology Scientific Meeting and Education Day

November 13 - 16, 2014 Miami Beach, Florida

Oncologist, Physician, Physician Researcher
Advances in Cancer Immunotherapies 2014 (ACI2014)
Singapore
10/15/2014

Advances in Cancer Immunotherapies 2014 (ACI2014)

October 15 - 16, 2014 Singapore

ACI2014 looks at key market drivers and factors impacting growth on the adoption of immunotherapy strategies, and how its expanding use against cancer is delivering healthcare solutions that hold new therapeutic promises for cancer patients. Our stellar panel of speakers from the biomedical research, healthcare and biopharmaceutical sectors will discuss the latest and future developments in immunotherapy research; review the therapeutic potentials of cancer immunotherapies and targeted therapies; and examine the challenges as well as opportunities accompanying this new generation of innovative biopharmaceuticals fuelling growth in the oncology market.

Key Topics Include

New approaches and strategies to optimize cancer immunotherapy

Monoclonal antibodies in cancer targeted therapy

Anti-cancer vaccines in preventive medicine

Immunogene therapy

Immunomodulatory agents in cancer

Combination therapies and non-specific immunotherapies

Recent advances and future applications in cancer therapy

5 Good Reasons Why You Should Attend

1. Interact with our international panel of speakers for their insights on emerging and future industry trends.

2. Network with decision-makers from leading and innovative companies for productive collaborations and business opportunities.

3. Connect with solution providers for innovative tools to accelerate and enable the success of preclinical research and development.

4. Explore with academia and researchers on novel research findings in cancer immunology that could be translated into clinical practice and drug development.

5. Invest your time with ASTRIK to understand the Now, know the Next and be empowered to take your business forward in the right direction.

Who Should Attend

Decision-makers from the Biopharmaceuticals, Pharmaceuticals, Healthcare, Biotechnology and Biomedical research sectors who are specialized in:

• Oncology

• Immunology

• Immunotherapy

• Molecular biology

• Antibody therapy

• Tumor antigen discovery

• Vaccine development

• Cancer biomarkers

• Disease therapeutic target

• Translational research

• Biotherapy

• Strategic collaboration

Immunologist, Molecular Biologist, Oncologist, Physician Researcher, Virologist
3rd Biomarkers in Diagnostics & Therapeutics 2014 (BDT2014)
Singapore
09/24/2014

3rd Biomarkers in Diagnostics & Therapeutics 2014 (BDT2014)

24 - 25 Sep 2014 Singapore

The burgeoning field of biomarkers has garnered a great deal of attention for its potential applications in molecular diagnostics as well as drug discovery and development (DDD). Over the last decade, much progress has been made in identifying and validating new biomarkers which enables the intimate monitoring of chronic human diseases from onset to progression, as well as providing a beacon to reveal high risk subpopulation for which the implementation of preventive and personalized healthcare is brought closer to reality. With the advent of research platforms that provide infrastructure, expertise, and technological innovations to condense the gap between scientific discovery and clinical application, there is hope of maximising the clinical potential of biomarkers in reality. Biomarker discovery and development are prominent in major therapeutic market areas (namely Cancer, Cardiovascular diseases and CNS diseases) and their applications to disease screening, diagnosis and monitoring of treatment efficacy demonstrates a changing therapeutic paradigm and healthcare landscape.

ASTRIK’s BDT conference series started by exploring the application potential of biomarkers research in molecular diagnostics and drug development, and goes on to examining new research targets and discovery strategies driving the translation of biomarker towards clinical applications. The 3rd edition will continue to lead a stellar panel of speakers to inspect the market outlooks and industry trends for biomarker diagnostics, technologies and services.  The theme for BDT2014 - Catalysing the Paradigm Shift in Healthcare - locks the conference focus on the diagnostic and therapeutic potentials of novel disease biomarkers and how innovations in technology platform capability enables applications that go towards fuelling transformations of the healthcare sector.

The global biomarkers market displays high growth potential in the near future with a projected value of 40.8 billion by 2018. Biomarker applications are wide and serve to drive changes in the healthcare landscape and reshape approaches to disease management. Do you have the latest map in hand to strategise developmental plans in tandem with the future paradigm?

Key Conference Topics

Chronic biomarkers in disease screening and monitoring

Functional biomarkers in major therapeutic areas: Cancer, Cardiovascular disease and CNS diseases

Imaging biomarkers for non-invasive diagnostic

Exosomes as a biomarker treasure chest

Epigenomics, metabolomics and microRNA as new sources of disease biomarkers

Innovations in technology platform capability enabling biomarker applications

Regulatory guidance for biomarker validation and qualification

5 Good Reasons Why You Should Attend

1. Interact with our international panel of speakers for their insights on emerging and future industry trends.

2.Network with decision-makers from leading and innovative companies for collaborations and business opportunities.

3. Connect with solution providers for innovative technology platforms, discovery instruments and tools to accelerate biomarker development.

4. Explore with academia and researchers on new research findings that could lead to discovery of novel biomarker candidate.

5. Invest your time with ASTRIK to understand the Now, know the Next and be empowered to take your business forward in the right direction.

Who Should Attend

Decision-makers from the Diagnostics, Biotechnology, Pharmaceutical, Healthcare and Academic sectors who are specialized in:

• Biomarker discovery and development

• Biomarker validation and qualification

• Bioimaging

• Proteomics

• Genomics

• Pharmaco-genomics

• Drug discovery and development

• Epigenomics

• Metabolomics

• MicroRNA

• Exosomes

• Molecular diagnostics

• Diagnostic systems

• Translational medicine

• Predictive, preventive and personalized medicine

• Clinical pharmacology

• Clinical research

• Oncology

• Cardiovascular diseases

• CNS diseases

Clinical Pharmacist, Molecular Biologist, Pharmacologist, Physician Researcher
13th International Conference on Malignant Lymphoma
Switzerland
06/17/2015

13th International Conference on Malignant Lymphoma

June 17-20, 2015 Lugano, Switzerland

The 13th International Conference on Malignant Lymphoma, the most important international forum devoted to basic and clinical research in lymphoid neoplasms, will take place in June 2015. Basic and clinical data will be presented during the sessions, focused not on a specific morphologic subtype, but rather on pathways or other biological aspects (e.g. microenvironment, immune system, chromosomal abnormalities, etc.). New sessions, such as the Educational Symposia, the special sessions devoted to radiotherapy and the ongoing trials presentation, were introduced in 2013 and, thanks to the many positive feedbacks, they will be repeated. Immediately after the Kaplan Lecture, worldwide known experts will discuss the best 3-4 accepted abstracts during a Plenary Session.

Hematologist, Oncologist, Physician Researcher, Radiation Oncologist
Melanoma Bridge 2014
Italy
12/03/2014

Melanoma Bridge 2014

December 3rd-6th, 2014 Naples, Italy

Melanoma Bridge 2014, jointly organized by Istituto Nazionale Tumori Fondazione "G. Pascale", Fondazione Melanoma Onlus and Sidra Medical and Research Center, together with the Society for ImmunoTherapy of Cancer (SITC), will be held on December 3rd-6th at the Royal Continental Hotel in Naples, Italy.

The Scientific Board of Melanoma Bridge, including well-known experts covering different areas and based in different Countries, aims at achieving a broad-based participation by various groups and societies sharing a clinical or basic interest in the immunology and the biology of the cancer microenvironment. The scientific program of the meeting will be organized in 6 sessions:

Molecular and Immuno advances;

Combination therapies;

News in Immunotherapy;

Tumor microenvironment and biomarkers;

World-Wide Immunoscore Task Force: an update

Round Table on regulatory issues of melanoma drugs

As traditional at Melanoma Bridge, representatives of melanoma patient associations will have their chance to actively join the event.

Oncologist, Physician Researcher
18th Annual Meeting of the Collaborative Group of the Americas on Inherited Colorectal Cancer
United States
Louisiana
09/15/2014

18th Annual Meeting of the Collaborative Group of the Americas on Inherited Colorectal Cancer

September 15-16, 2014 New Orleans, Louisiana

Oncologist, Physician, Physician Researcher
International Society of Geriatric Oncology 2014 Annual Meeting
Portugal
10/23/2014

International Society of Geriatric Oncology 2014 Annual Meeting

October 23-25, 2014 Lisbon, Portugal

The SIOG 2014 Annual Meeting will take place in Lisbon, Portugal on October 23-25, 2014.

SIOG annual conference is the leading conference for experts in the field for geriatric oncology. The event provides a unique platform for researchers, clinical practitioners in oncology, geriatricians, radiologists, psychologists, nutritionists, nurses, senior cancer survivors advocates to learn, interact and share results and best practice. It also allows for important improvements in the understanding and the practice of this multidisciplinary approach when treating senior adults with cancer. The conference features speakers from among the world’s leading experts in the fields.

The event provides an unparalleled opportunity for active representatives from the entire spectrum of the geriatric oncology community to attend and learn, including scientists, researchers, healthcare professionals and individuals, all of whom want to be seen at the forefront of this multidisciplinary approach.

The SIOG Annual Conference enables participants to:

Learn from the experience of peers

Showcase their expertise on a global stage

Demonstrate their commitment to the multidisciplinary approach to treat cancer in the elderly

Network with leaders from across the oncology and geriatric communities

Allied Health Professional, Dietitian, Geriatrician, Gerontological Nurse, Nurse, Nutritionist, Oncologist, Psychologist, Radiation Oncologist, Radiologist, Social Worker
Academy of Oncology Nurse & Patient Navigators Fifth Annual Navigation and Survivorship Conference
United States
Florida
09/18/2014

Academy of Oncology Nurse & Patient Navigators Fifth Annual Navigation and Survivorship Conference

September 18-21, 2014 Orlando, Florida

The Fifth Annual Academy of Oncology Nurse and Patient Navigators (AONN+) Conference will continue to advance the navigation profession by expanding the scope of educational sessions, networking opportunities, and poster presentations.

Who Should Attend

All clinical and nonclinical professionals involved or interested in patient navigation and survivorship. This conference will enhance the skills and knowledge of:

• Oncology Nurse Navigators

• Patient Navigators

• Oncology Social Workers

• Administrators

• Case Managers

• Care Managers

• Oncology Nurses & Nurse Practitioners

• Practice Managers

Nurse, Nurse Researcher, Social Worker
16th World Congress of Psycho-Oncology and Psychosocial Academy
Portugal
10/20/2014

16th World Congress of Psycho-Oncology and Psychosocial Academy

October 20-24, 2014 Lisbon, Portugal

Congress Theme: Integrating Psycho-Oncology Into Mainstream Cancer Care; From Research to Action

Nurse, Nurse Researcher, Oncologist, Physician, Physician Researcher, Social Worker
2014 Breast Cancer Symposium
United States
California
09/04/2014

2014 Breast Cancer Symposium

September 4-6, 2014 San Francisco, California

Gynecologist, Oncologist, Physician, Physician Researcher

prev13next